NRSN – neurosense therapeutics ltd. (US:NASDAQ)
Stock Stats
News
NeuroSense Therapeutics Announces Transformative Phase 2b MicroRNA Data, Highlighting PrimeC's Promise as a Disease-Modifying ALS Treatment [Yahoo! Finance]
NeuroSense Therapeutics Announces Transformative Phase 2b MicroRNA Data, Highlighting PrimeC's Promise as a Disease-Modifying ALS Treatment
NeuroSense Therapeutics Reports Year End 2024 Financial Results and Provides Business Updates
NeuroSense Therapeutics to Present New Data from PrimeC's Phase 2b Trial in ALS at the Annual American Academy of Neurology Meeting
Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug [Yahoo! Finance]
Form POS AM NeuroSense Therapeutics
Form POS AM NeuroSense Therapeutics
Form 6-K NeuroSense Therapeutics For: Apr 07
Form 20-F NeuroSense Therapeutics For: Dec 31
Form 6-K NeuroSense Therapeutics For: Mar 27
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.